Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$105,000.00
Chemical-chemical combinations: as tools to elucidate mechanism of action and as routes to drug discovery.
EF 2010-11
Résumé
The new field of systems biology is shedding light on the nature of cellular organization in microbes. New information suggests that cellular components exhibit network-like behaviour that is buffered by plasticity and redundancy. This reality exposes flaws in the conventional one-drug-one-target route in drug discovery and in probe development, predicting that drug combinations should have considerable advantages over one-drug approaches. In the proposed work, we will exploit this capacity with studies involving chemical combinations for a task as critical as characterizing modes of action for uncharted compounds and gaining insights into the complex biological network. We have previously shown the utility of a novel high-throughput methodology for target identification; the ability to gauge information about the pathway a compound of interest is involved in based solely on phenotypic responses to combinatory studies provides a simple and useful method for screening novel chemical matter. Full characterization of the mode of action of new bioactive molecules will add to our growing repertoire of bacterial growth inhibitory molecules. Additionally, from a drug discovery perspective, our new understanding of cell complexity strongly suggests that combinations of small molecules will have greater benefits in achieving maximum therapeutic effects. Thus, we propose to strategically survey the full combination matrix of 2,000 existing drugs through pooled screening for new synergistic combinations with therapeutic potential. Further, a screen for combinations of molecules that affect the different components of bacterial proton motive force will yield novel effective synergistic interactions. Overall, where traditional drug discovery approaches have largely overlooked systematic searches for chemical combinations, new information strongly suggests that combinations of small molecules will have a unique and powerful capacity as probes and as antimicrobial agents.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
229659
Name
Farha Maya A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Chemical-chemical combinations: as tools to elucidate mechanism of action and as routes to drug discovery.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bacterial Microbiology; Checkerboard Analysis; Chemical Combinations; Enzymatic Assays; High-Throughput Screening; Minimum Inhibitory Concentrations; Protein Purification; Synergistic Interactions; Synthetic Small Molecule Libraries; Target Identification
Abstract
The new field of systems biology is shedding light on the nature of cellular organization in microbes. New information suggests that cellular components exhibit network-like behaviour that is buffered by plasticity and redundancy. This reality exposes flaws in the conventional one-drug-one-target route in drug discovery and in probe development, predicting that drug combinations should have considerable advantages over one-drug approaches. In the proposed work, we will exploit this capacity with studies involving chemical combinations for a task as critical as characterizing modes of action for uncharted compounds and gaining insights into the complex biological network. We have previously shown the utility of a novel high-throughput methodology for target identification; the ability to gauge information about the pathway a compound of interest is involved in based solely on phenotypic responses to combinatory studies provides a simple and useful method for screening novel chemical matter. Full characterization of the mode of action of new bioactive molecules will add to our growing repertoire of bacterial growth inhibitory molecules. Additionally, from a drug discovery perspective, our new understanding of cell complexity strongly suggests that combinations of small molecules will have greater benefits in achieving maximum therapeutic effects. Thus, we propose to strategically survey the full combination matrix of 2,000 existing drugs through pooled screening for new synergistic combinations with therapeutic potential. Further, a screen for combinations of molecules that affect the different components of bacterial proton motive force will yield novel effective synergistic interactions. Overall, where traditional drug discovery approaches have largely overlooked systematic searches for chemical combinations, new information strongly suggests that combinations of small molecules will have a unique and powerful capacity as probes and as antimicrobial agents.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Farha, Maya A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~